A Quantitative Systems Pharmacology Model of Glucose-Insulin Regulation to Guide the Design and Evaluation of Novel Basal Insulins with Optimal Risk-Benefit Profile

被引：0

|

作者：

Geiser, Jeanne ^{[1
]}

Garhyan, Parag ^{[1
]}

Chien, Jenny ^{[1
]}

机构：

[1] Eli Lilly & Co, Indianapolis, IN 46285 USA

来源：

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS | 2018年 / 45卷

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

T-015

引用

收藏

页码：S53 / S53

页数：1

相关论文

共 2 条

[1] Designing Optimal Basal Insulin Analogs Using a Quantitative Systems Pharmacology Model
Kumar, Rukmini
Geiser, Jeanne
Leohr, Jennifer
Leishman, Derek
Topp, Brian
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2014, 41 : S20 - S20
[2] Leveraging a Quantitative Systems Pharmacology Model to Explore the Mechanism of Action of a Novel Basal Insulin Analog
Garhyan, Parag
Kumar, Rukmini
Geiser, Jeanne
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S74 - S74